Molbio Diagnostics Ltd, slated to list on the BSE and NSE, has announced its mainboard IPO price band at ₹768–₹807, with a lot size of 18 shares and a minimum retail investment of ₹14,526. The issue is scheduled to open on 10 August 2026 and close on 12 August 2026.
Molbio Diagnostics operates in the point‑of‑care molecular diagnostics space, developing portable, rapid testing platforms for the diagnosis of infectious and non‑communicable diseases, including its flagship Truenat real‑time PCR system, which is battery operated and recognised by global health authorities ([molbiodiagnostics.com](https://www.molbiodiagnostics.com/who-we-are/?utm_source=openai)).
| Price Band | ₹768–₹807 |
| Lot Size | 18 shares |
| Minimum Investment (Retail) | ₹14,526 |
| Issue Opens | 10 Aug 2026 |
| Issue Closes | 12 Aug 2026 |
| Exchange | BSE, NSE |
Track live GMP and subscription numbers as the issue approaches on the Molbio Diagnostics Ltd IPO page.
Price bands and dates are as announced and may be revised by the company or exchange before the issue opens.